Cargando…

An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression

BACKGROUND: Many patients with major depressive disorder (MDD) fail to respond to antidepressant (AD) pharmacotherapy. The objectives of this study were to characterize MDD and treatment-resistant depression (TRD) at the level of pharmacologically treated episodes and to describe the sequential trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bingcao, Cai, Qian, Sheehan, John J., Benson, Carmela, Connolly, Nancy, Alphs, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687173/ https://www.ncbi.nlm.nih.gov/pubmed/31393922 http://dx.doi.org/10.1371/journal.pone.0220763

Ejemplares similares

Economic Burden of Treatment‐Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States
por: Lin, Jay, et al.
Publicado: (2019)

The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reporting Moderately Severe or Severe Major Depressive Disorder in a National Survey
por: Benson, Carmela, et al.
Publicado: (2021)

Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression
por: Turkoz, Ibrahim, et al.
Publicado: (2021)

Treatment Patterns During Major Depressive Episodes Among Patients with Major Depressive Disorder: A Retrospective Database Analysis
por: Jain, Rakesh, et al.
Publicado: (2022)

Association of Major Depressive Episode with Negative Outcomes of Tuberculosis Treatment
por: Ugarte-Gil, Cesar, et al.
Publicado: (2013)

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová, Martina, et al.
Publicado: (2019)

Decreased Functional Connectivity in Insular Subregions in Depressive Episodes of Bipolar Disorder and Major Depressive Disorder
por: Yin, Zhiyang, et al.
Publicado: (2018)

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study
por: Del Casale, Antonio, et al.
Publicado: (2022)

Perceptive Biases in Major Depressive Episode
por: Naudin, Marine, et al.
Publicado: (2014)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009)

Does Age at Onset of First Major Depressive Episode Indicate the Subtype of Major Depressive Disorder?: The Clinical Research Center for Depression Study
por: Park, Seon-Cheol, et al.
Publicado: (2014)

Repetitive Transcranial Magnetic Stimulation Combined with Anti-depressants for the First Episode of Major Depressive Disorder
por: Maneeton, Benchalak, et al.
Publicado: (2020)

Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
por: Sharman Moser, Sarah, et al.
Publicado: (2022)

Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder
por: Kaur, Mandeep, et al.
Publicado: (2021)

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression
por: Kosanovic Rajacic, Biljana, et al.
Publicado: (2023)

Brief major depressive episode as an essential predictor of the Bipolar Spectrum Disorder
por: Shabani, Amir, et al.
Publicado: (2009)

Familiality and SNP heritability of age at onset and episodicity in major depressive disorder
por: Ferentinos, P., et al.
Publicado: (2015)

The association between suicide risk and self-esteem in Japanese university students with major depressive episodes of major depressive disorder
por: Mitsui, Nobuyuki, et al.
Publicado: (2014)

Osteocalcin levels decrease during the treatment of an acute depressive episode
por: Bartečků, Elis, et al.
Publicado: (2022)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

Baseline predictors of cognitive change in the treatment of major depressive episode: systematic review
por: Barczyk, Zoe A., et al.
Publicado: (2020)

Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia
por: Basu, Anirban, et al.
Publicado: (2018)

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
por: Kern, David M., et al.
Publicado: (2023)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

Rediscovering Trazodone for the Treatment of Major Depressive Disorder
por: Fagiolini, Andrea, et al.
Publicado: (2012)

Treatment of Major Depressive Disorder in Pediatric Populations
por: Neavin, Drew R., et al.
Publicado: (2018)

Pharmacological Treatment of Major Depressive Disorder in Adolescents
por: Farley, Rachel L.
Publicado: (2005)

Blood cytokines differentiate bipolar disorder and major depressive disorder during a major depressive episode: Initial discovery and independent sample replication
por: Martinuzzi, Emanuela, et al.
Publicado: (2021)

Regional increases of cortical thickness in untreated, first-episode major depressive disorder
por: Qiu, L, et al.
Publicado: (2014)

Abnormalities in Electroencephalographic Microstates Among Adolescents With First Episode Major Depressive Disorder
por: He, Yuqiong, et al.
Publicado: (2021)

Alterations of brainstem volume in patients with first-episode and recurrent major depressive disorder
por: Chen, Yue, et al.
Publicado: (2023)

Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders
por: Costa, Mônica V., et al.
Publicado: (2016)

Clinical Relevance of Vilazodone Treatment in Patients With Major Depressive Disorder: Categorical Improvement in Symptoms
por: Culpepper, Larry, et al.
Publicado: (2014)

Characteristics Associated with Depression Severity in 270 Juveniles in a Major Depressive Episode
por: Serra, Giulia, et al.
Publicado: (2021)

Gender Differences in the Psychopathology of Mixed Depression in Adolescents with a Major Depressive Episode
por: Apicella, Massimo, et al.
Publicado: (2023)

Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders
por: Cui, Feihuan, et al.
Publicado: (2021)

Eight‐week antidepressant treatment reduces functional connectivity in first‐episode drug‐naïve patients with major depressive disorder
por: Li, Le, et al.
Publicado: (2021)

Cross-national epidemiology of DSM-IV major depressive episode
por: Bromet, Evelyn, et al.
Publicado: (2011)

Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
por: Khan, Arif, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v11jb8dq1ubjq2pq2eaku3a3qd